vs

Side-by-side financial comparison of BGSF, INC. (BGSF) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.

BGSF, INC. is the larger business by last-quarter revenue ($22.0M vs $18.9M, roughly 1.2× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -5.3%, a 19.9% gap on every dollar of revenue. On growth, Electromed, Inc. posted the faster year-over-year revenue change (16.3% vs -9.4%). Electromed, Inc. produced more free cash flow last quarter ($2.4M vs $1.7M). Over the past eight quarters, Electromed, Inc.'s revenue compounded faster (16.7% CAGR vs -5.3%).

BGSF Inc. is a leading U.S.-headquartered workforce solutions firm that provides tailored staffing, talent recruitment, and end-to-end workforce management services. It serves core segments including information technology, healthcare, professional administration, light industrial, and creative industries, catering to small, mid-sized and large enterprise clients across North America.

Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.

BGSF vs ELMD — Head-to-Head

Bigger by revenue
BGSF
BGSF
1.2× larger
BGSF
$22.0M
$18.9M
ELMD
Growing faster (revenue YoY)
ELMD
ELMD
+25.6% gap
ELMD
16.3%
-9.4%
BGSF
Higher net margin
ELMD
ELMD
19.9% more per $
ELMD
14.6%
-5.3%
BGSF
More free cash flow
ELMD
ELMD
$722.0K more FCF
ELMD
$2.4M
$1.7M
BGSF
Faster 2-yr revenue CAGR
ELMD
ELMD
Annualised
ELMD
16.7%
-5.3%
BGSF

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
BGSF
BGSF
ELMD
ELMD
Revenue
$22.0M
$18.9M
Net Profit
$-1.2M
$2.8M
Gross Margin
35.0%
78.4%
Operating Margin
-17.6%
19.2%
Net Margin
-5.3%
14.6%
Revenue YoY
-9.4%
16.3%
Net Profit YoY
-18.2%
40.3%
EPS (diluted)
$-0.12
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BGSF
BGSF
ELMD
ELMD
Q4 25
$22.0M
$18.9M
Q3 25
$26.9M
$16.9M
Q2 25
$23.5M
$17.4M
Q1 25
$20.9M
$15.7M
Q4 24
$24.3M
$16.3M
Q3 24
$29.8M
$14.7M
Q2 24
$25.7M
$14.8M
Q1 24
$24.5M
$13.9M
Net Profit
BGSF
BGSF
ELMD
ELMD
Q4 25
$-1.2M
$2.8M
Q3 25
$-5.8M
$2.1M
Q2 25
$-3.7M
$2.2M
Q1 25
$-722.0K
$1.9M
Q4 24
$-981.0K
$2.0M
Q3 24
$-804.0K
$1.5M
Q2 24
$-761.0K
$1.8M
Q1 24
$-792.0K
$1.5M
Gross Margin
BGSF
BGSF
ELMD
ELMD
Q4 25
35.0%
78.4%
Q3 25
35.9%
78.1%
Q2 25
35.8%
78.3%
Q1 25
36.2%
78.0%
Q4 24
35.9%
77.7%
Q3 24
35.9%
78.3%
Q2 24
37.3%
76.2%
Q1 24
38.1%
74.8%
Operating Margin
BGSF
BGSF
ELMD
ELMD
Q4 25
-17.6%
19.2%
Q3 25
-3.5%
15.8%
Q2 25
-18.8%
17.5%
Q1 25
1.6%
13.6%
Q4 24
-15.7%
15.6%
Q3 24
-3.4%
13.2%
Q2 24
-5.7%
15.7%
Q1 24
1.7%
13.3%
Net Margin
BGSF
BGSF
ELMD
ELMD
Q4 25
-5.3%
14.6%
Q3 25
-21.6%
12.6%
Q2 25
-15.9%
12.7%
Q1 25
-3.5%
12.1%
Q4 24
-4.0%
12.1%
Q3 24
-2.7%
10.0%
Q2 24
-3.0%
12.3%
Q1 24
-3.2%
10.8%
EPS (diluted)
BGSF
BGSF
ELMD
ELMD
Q4 25
$-0.12
$0.32
Q3 25
$-0.52
$0.25
Q2 25
$-0.34
$0.26
Q1 25
$-0.06
$0.21
Q4 24
$0.22
Q3 24
$-0.07
$0.16
Q2 24
$-0.07
$0.20
Q1 24
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BGSF
BGSF
ELMD
ELMD
Cash + ST InvestmentsLiquidity on hand
$13.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$48.1M
$45.4M
Total Assets
$57.8M
$54.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BGSF
BGSF
ELMD
ELMD
Q4 25
$13.8M
Q3 25
$41.2M
$14.1M
Q2 25
$2.8M
$15.3M
Q1 25
$2.0M
$15.2M
Q4 24
$32.0K
$16.2M
Q3 24
$262
$13.9M
Q2 24
$226
$16.1M
Q1 24
$50
$11.7M
Stockholders' Equity
BGSF
BGSF
ELMD
ELMD
Q4 25
$48.1M
$45.4M
Q3 25
$50.7M
$44.7M
Q2 25
$78.3M
$43.2M
Q1 25
$81.8M
$43.9M
Q4 24
$82.3M
$43.6M
Q3 24
$82.9M
$41.5M
Q2 24
$83.2M
$44.5M
Q1 24
$83.6M
$42.5M
Total Assets
BGSF
BGSF
ELMD
ELMD
Q4 25
$57.8M
$54.9M
Q3 25
$83.6M
$53.6M
Q2 25
$149.7M
$53.8M
Q1 25
$152.3M
$52.5M
Q4 24
$150.1M
$52.3M
Q3 24
$157.3K
$48.9M
Q2 24
$159.8K
$52.2M
Q1 24
$170.6K
$48.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BGSF
BGSF
ELMD
ELMD
Operating Cash FlowLast quarter
$1.7M
$3.0M
Free Cash FlowOCF − Capex
$1.7M
$2.4M
FCF MarginFCF / Revenue
7.6%
12.7%
Capex IntensityCapex / Revenue
0.1%
3.4%
Cash ConversionOCF / Net Profit
1.10×
TTM Free Cash FlowTrailing 4 quarters
$-16.0K
$7.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BGSF
BGSF
ELMD
ELMD
Q4 25
$1.7M
$3.0M
Q3 25
$-4.8M
$169.0K
Q2 25
$2.2M
$3.9M
Q1 25
$1.1M
$2.1M
Q4 24
$3.2M
$3.2M
Q3 24
$6.5M
$2.3M
Q2 24
$7.3M
$4.5M
Q1 24
$7.4M
$1.4M
Free Cash Flow
BGSF
BGSF
ELMD
ELMD
Q4 25
$1.7M
$2.4M
Q3 25
$-4.9M
$-83.0K
Q2 25
$2.1M
$3.7M
Q1 25
$1.0M
$1.9M
Q4 24
$2.5M
$2.9M
Q3 24
$6.5M
$2.3M
Q2 24
$7.3M
$4.5M
Q1 24
$6.9M
$1.3M
FCF Margin
BGSF
BGSF
ELMD
ELMD
Q4 25
7.6%
12.7%
Q3 25
-18.1%
-0.5%
Q2 25
9.1%
21.4%
Q1 25
5.0%
12.2%
Q4 24
10.2%
18.0%
Q3 24
21.7%
15.5%
Q2 24
28.5%
30.1%
Q1 24
28.1%
9.1%
Capex Intensity
BGSF
BGSF
ELMD
ELMD
Q4 25
0.1%
3.4%
Q3 25
0.4%
1.5%
Q2 25
0.0%
0.8%
Q1 25
0.1%
1.0%
Q4 24
3.0%
1.4%
Q3 24
0.0%
0.3%
Q2 24
0.0%
0.1%
Q1 24
2.0%
0.6%
Cash Conversion
BGSF
BGSF
ELMD
ELMD
Q4 25
1.10×
Q3 25
0.08×
Q2 25
1.75×
Q1 25
1.10×
Q4 24
1.60×
Q3 24
1.57×
Q2 24
2.46×
Q1 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BGSF
BGSF

Contract Field Talent$21.4M97%
Other$595.0K3%

ELMD
ELMD

Homecare$17.3M91%
Other$1.6M9%

Related Comparisons